News | Cardiac Diagnostics | October 06, 2020

Rapid Heart Function Analysis by Avalon-H90 Device May Identify Myocarditis In COVID-19 Patients

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum interference device (SQUID)-based magnetometers is being used for heart screenings and may be able to quickly detect myocarditis in COVID-19 patients without any physical contact. The medical device called Avalon-H90.

COVID-19 causes myocarditis in many of those infected. So, there is a need for fast, noninvasive and reliable heart screening for all patients who were affected by COVID-19 and potentially developed myocarditis.

According to the article published by Ohio State University Sept. 11, 2020 in medical journal JAMA, 26 competitive athletes who had COVID-19 had symptoms of myocarditis.[1] Myocarditis affects the heart muscle and can cause heart failure or sudden death. Steven Erickson, M.D., a sports medicine specialist at Banner — University Medical Center in Phoenix, Ariz., told USA Today that athletes should be symptom-free for two weeks before getting back into the game.

Although widely used as a screening tool, the sensitivity of electrocardiogram (ECG) for myocarditis is only less than 50 percent and is very non-specific. The most common ECG findings are non-specific T-wave changes.

The Mesuron team believes its technology is most sensitive to detect any T-wave changes. It is fast, non-invasive, no injection, no radiation, no contact, high sensitivity at rest detection of ventricular myocardial repolarization abnormalities, that reflects several myocardial problems, including ischemia.

Mesuron Inc. has developed Ventricular Repolarization Dynamics Analysis (VRDA) on the Avalon-H90 that detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential (EAP) of normal heart tissues and abnormal ones with hypoxia. The vendor says is also robust enough to detect abnormalities without hypoxia due to changes in muscle chemistry related to insufficient blood supply or other myocardial abnormalities.

Avalon-H90 takes approximately 5 minutes to deliver test results that can separate high and low risk cardiac patients and help the physician make early decisions.

Avalon-H90 is a fully developed prototype. It is designed for use in hospitals' emergency departments and outpatient clinics. The company is looking for partnerships to conduct a medical trial for detecting myocardial abnormalities in acute chest pain (ACP) patients. One trial has already been arranged with Mayo Clinic. 

For more information: www.mesuron.com

Read more about this technology being developed by another start up company:

Key Technology and News at AHA 2018

VIDEO: Editor's Choice of the Most Innovative New Cardiac Technology at AHA 2018
 

    

Reference:

1. Saurabh Rajpal, Matthew S. Tong, James Borchers, et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. Published online September 11, 2020. doi:10.1001/jamacardio.2020.4916.

 
 

Related Content

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
Videos | Cardiac Diagnostics | October 29, 2019
Doctor Clyde Yancy was a keynote speaker and said doctors need to check their assumptions about patients at the door...
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...
Pesticide Exposure May Increase Heart Disease and Stroke Risk

Image courtesy of zefe wu from Pixabay

News | Cardiac Diagnostics | October 15, 2019
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy...
World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...
Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...